İpucu modu açıktır Kapat

SBIO - ALPS Medical Breakthroughs ETF (USD) (US00162Q5936)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Hepsini seç Hepsini sıfırla
 
(%)
US00162Q5936
SBIO ISIN
Borsa Yatırım Fonları (BYF)
Fon türü
ALPS Advisors
Sağlayıcı
54,25 USD
Hisse başına net varlık değeri | 08.04.2026
29.12.2014
Başlangıç ​​tarihi
1 yılda ... kez
Temettü ödemeleri
CEOJMS
CFI
SBIO
Menkul değer sembolü
Formed
Status
Equity
Yatırım kategorisi
Biotech
Sektör
USA
Coğrafya
S-Network Medical Breakthroughs Index
Karşılaştırma ölçütü (benchmark)
0.5 %
Toplam Maliyet Oranı
136,98 milyon USD
Fonun toplam varlıkları | 08.04.2026
136,98 milyon USD
Hisse senedi sınıfı varlıkları | 08.04.2026
Hayır
UCITS

Getiri on 08.04.2026, NYSE Arca

  • YTD
    8,35 %
  • 1M
    9,01 %
  • 3M
    7,47 %
  • 6M
    32,92 %
  • 1Y
    130,39 %
  • 3Y
    108,25 %
  • 5Y
    16,39 %
  • 10Y
    144,17 %
Gelir ödemeleri dikkate alınarak borsadaki fiyat üzerinden

Şu tarihe ilişkin son veriler
Karşılaştırmak için öğe ekleyin
başlangıç
bitiş
ADD-IN
Cbonds Eklentisi API
bond data api

Kotasyonlar (SBIO)

En kapsamlı veri tabanını keşfedin

1 000 000

tahvi̇ller

80 234

hisse senetleri

167 970

ETF & Funds

80 000

endeksler

Portföyünüzü en etkili şekilde takip edin

  • Tahvi̇l arama
  • Watchlist
  • Excel Eklentisi
Erişim sağlamak

Fiyat dinamiklerindeki değişimler

SBIO profile

The ALPS Medical Breakthroughs ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The ALPS Advisors fund’s base currency is USD and the share class was registered 29.12.2014 with unique ISIN - US00162Q5936. Main exchange is NYSE Arca and ticker symbol is SBIO. The total expense ratio is 0.5%. The ALPS Medical Breakthroughs ETF (USD) pays dividends 1 time(s) per year.

Yapı SBIO on 08.04.2026

Excel'de yapıyı indir
Menkul kıymet Değer
Kymera Therapeutics Inc. 4,23%
Mirum Pharmaceuticals Inc. 3,51%
CG oncology Inc. 3,45%
Alkermes PLC 3,44%
Celcuity Inc. 3,22%
Apellis Pharmaceuticals Inc. 3,09%
Xenon Pharmaceuticals Inc. 2,84%
Apogee Therapeutics Inc. 2,77%
Amicus Therapeutics Inc. 2,7%
Crinetics Pharmaceuticals Inc. 2,48%
Spyre Therapeutics Inc. 2,43%
Newamsterdam Pharma Co. NV 2,32%
Viking Therapeutics Inc. 2,31%
Dianthus Therapeutics Inc. 2,31%
ACADIA Pharmaceuticals Inc. 2,29%
Structure Therapeutics Inc. 2,23%
Edgewise Therapeutics Inc. 2,11%
Denali Therapeutics Inc. 1,85%
Tarsus Pharmaceuticals Inc. 1,82%
Oruka Therapeutics Inc. 1,78%
Travere Therapeutics Inc. 1,74%
Vera Therapeutics Inc. 1,71%
Ideaya Biosciences Inc. 1,62%
Relay Therapeutics Inc. 1,54%
Disc Medicine Inc. 1,5%
Zai Lab Ltd. 1,42%
Sarepta Therapeutics Inc. 1,37%
Day One Biopharmaceuticals Inc. 1,32%
Mineralys Therapeutics Inc. 1,31%
Celldex Therapeutics Inc. 1,28%
Tyra Biosciences Inc. 1,19%
Stoke Therapeutics Inc. 1,18%
Agios Pharmaceuticals Inc. 1,18%
Galapagos NV 1,13%
Amylyx Pharmaceuticals Inc. 1,11%
Pharvaris NV 1,05%
Vericel Corp. 1,03%
Palvella Therapeutics Inc. 1%
Sionna Therapeutics Inc. 0,99%
Rapport Therapeutics Inc. 0,96%
Immunocore Holdings PLC 0,96%
Nuvation Bio Inc. 0,93%
Oculis Holding AG 0,92%
MBX Biosciences Inc. 0,84%
Immatics NV 0,84%
Novavax Inc. 0,82%
Bicara Therapeutics Inc. 0,81%
Maze Therapeutics Inc. 0,8%
MoonLake Immunotherapeutics 0,79%
Corvus Pharmaceuticals Inc. 0,74%
Taysha Gene Therapies Inc. 0,74%
Olema Pharmaceuticals Inc. 0,73%
Zenas Biopharma Inc. 0,67%
ArriVent Biopharma Inc. 0,66%
Geron Corp. 0,65%
KalVista Pharmaceuticals Inc. 0,58%
Compass Therapeutics Inc. 0,58%
Xencor Inc. 0,53%
Theravance Biopharma Inc. 0,5%
ARS Pharmaceuticals Inc. 0,48%
MannKind Corp. 0,48%
Design Therapeutics Inc. 0,46%
Kura Oncology Inc. 0,46%
Alto Neuroscience Inc. 0,4%
Tectonic Therapeutic Inc. 0,34%
Rigel Pharmaceuticals Inc. 0,33%
Upstream Bio Inc. 0,32%
Fulgent Genetics Inc. 0,29%
Zura Bio Ltd. 0,29%
Aclaris Therapeutics Inc. 0,28%
Atea Pharmaceuticals Inc. 0,28%
REGENXBIO Inc. 0,27%
Altimmune Inc. 0,26%
Vanda Pharmaceuticals Inc. 0,26%
Akebia Therapeutics Inc. 0,23%
Candel Therapeutics Inc. 0,22%
Delcath Systems Inc. 0,2%
Rezolute Inc. 0,2%
Neurogene Inc. 0,2%
Forte Biosciences Inc. 0,2%
Protara Therapeutics Inc. 0,17%
Anavex Life Sciences Corp. 0,17%
Bicycle Therapeutics PLC 0,15%
Arcturus Therapeutics Holdings Inc. 0,14%
Aardvark Therapeutics Inc. 0,05%
Chinook Therapeutics Inc. 0%
AstraZeneca PLC 0%
Novo Nordisk A/S 0%
Cash Equivalent -0,03%
Tümünü göster Gizle
Other - %

Bu sağlayıcıdan diğer ETF ve Fonlar

Benzer ETF ve Fonlar

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} milyon
    Net Varlık Değeri
    {{ item.expense_ratio }}
    Toplam Maliyet Oranı
Kayıt gereklidir erişim için